$35 Million Investment Raised By Precision Therapeutics
$35 Million Investment Raised By Precision Therapeutics
Bain Capital Ventures, the venture and growth affiliate of Bain Capital, recently led a financing of $35 million in Precision Therapeutics. The funding will be used to provide additional support for expanding the distribution of the Company’s core product, ChemoFx®, and to expedite their efforts in the research, development and commercialization of novel proteomic and genomic markers for cancer …
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Tumor Tags: Investment, million, Precision, raised, Therapeutics'
Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer
Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer
read more
Read more on SYS-CON Media
Categories: Breast Cancer Pain Tags: Announces, breast, cancer, From, initial, Metastatic, Nektar, NKTR102, Phase, positive, Results, Study, Therapeutics'
Regulus Therapeutics’ metabolic disease program data presented at Diabetes Keystone Symposium
Regulus Therapeutics’ metabolic disease program data presented at Diabetes Keystone Symposium
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the “Diabetes” Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having …
Read more on News-Medical-Net
Categories: Breast Cancer Research Tags: Data, Diabetes, Disease, Keystone, metabolic, presented, program, Regulus, Symposium, Therapeutics'
Prime Therapeutics to Present New Research at Academy of Managed Care Pharmacy Conference in April
Prime Therapeutics to Present New Research at Academy of Managed Care Pharmacy Conference in April
Prime Therapeutics LLC , a thought leader in pharmacy benefit management, will present five new studies at the Academy of Managed Care Pharmacy’s annual meeting, April 7-10, 2010 in San Diego.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Research Tags: Academy, April, Care, conference, Managed, Pharmacy, present, Prime, research, Therapeutics'
Research and Markets: Osteoporosis Drug Pipeline Report Reveals the Global Osteoporosis Therapeutics Market was Valued …
Research and Markets: Osteoporosis Drug Pipeline Report Reveals the Global Osteoporosis Therapeutics Market was Valued …
DUBLIN—-Research and Markets has announced the addition of GlobalData ‘s new report “Osteoporosis – Drug Pipeline Analysis and Market Forecasts to 2016″ to their offering.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Research Tags: drug, Global, Market, Markets, Osteoporosis, Pipeline, Report, research, reveals, Therapeutics', Valued